Merck & Co. stock is trading at USD 150.78 on September 2, 2026, while sales for Q2 2026 rose 5 perc

Merck & Co. stock is trading near its recent highs after fresh Phase 3 mRNA cancer data and the firs

Nwam LLC grew its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 93.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,971 shares of the company

Northwestern Mutual Wealth Management Co. cut its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 386,735 shares of the company

Merck & Co. stock is trading firmer as investors weigh fresh positive data from its personalized mel

Proficio Capital Partners LLC lifted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 93.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 36,360 shares of the company

August has been a great month for the shares of Merck & Co., Inc. (NYSE:MRK) and Moderna Inc. (NASDAQ:MRNA), to say the least. The former’s stock closed 12.6% higher and the latter’s stock closed 176% higher on August 19th. The stocks surged after a major announcement from Moderna Inc. (NASDAQ:MRNA) shared the results from its […]

Susquehanna Fundamental Investments LLC acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 89,259 shares of the company